Back Bay Local Business

Back Bay Local Business

Local business in Back Bay (Boston, MA)

  • Tuesday Jul 4 | via 

    Mass. biotech IPO drought over, but companies procee...

    While a pair of Cambridge-based cancer drug developers sold their shares last week in the first initial public offerings since January, there was little evidence their success was a harbinger of a new stampede of local biotechs into the public markets. Shares of Mersana Therapeutics Inc. and Aileron Therapeutics Inc., both considered companies that are working with cutting-edge technology, ended the week below their $15 offering prices after getting caught in Thursday's downdraft of stocks listed on the Nasdaq exchange.


    Related Topix: Cambridge, MA, Mersana Therapeutics, Back Bay (Boston, MA), Boston, MA